Osteonecrosis After Administration of Intravitreous Bevacizumab

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

Anne E. Fung, Philip J. Rosenfeld, Elias Reichel · British Journal of Ophthalmology · 2006 · 537 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 457 citations

Medicine, Ophthalmology, Surgery +16

Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration

Joyce Mordenti, R. Andrew Cuthbertson, Napoleone Ferrara et al. · Toxicologic Pathology · 1999 · 351 citations

Medicine, Ophthalmology, Pharmacokinetics +15

Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer

Salvatore L. Ruggiero, Julie R. Gralow, Robert E. Marx et al. · Journal of Oncology Practice · 2006 · 342 citations

Dentistry, Maxillofacial Surgery, Oral Medicine +13

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

Valentina Guarneri, David Miles, Nicholas J. Robert et al. · Breast Cancer Research and Treatment · 2010 · 285 citations · Full text

Medicine, Oncology, Breast Oncology +12